Process Development and Manufacturing Publications 

June Kim et al. Fast-Tracking Vaccine Manufacturing: CEPI’s Rapid Response Framework for the 100 Days Mission. Vaccines August 2025; 13(8)

Ramin Sabet-Azad, Catherine Hoath, Nicole Bézay and Anna Särnefält. The Platform Readiness Dashboard: A Tool for Evaluating Vaccine Platform Suitability for a Rapid Response to Epidemic and Pandemic Threats. Vaccines July 2025; 13(8)

Vishal Mukund Sonje and Valerie Chambard. Overcoming CMC, manufacturing, and supply chain challenges in vaccine production: a review of efforts in the Global South, with a focus on Africa. Vaccine Insights June 2025; 4(4)

Michael Anyadiegwu, Renske Hesselink, and Ingrid Kromann. The Need for Manufacturing Speed - Accelerating Vaccine Availability for Emergency Use Against Disease Threats. PDA Letter May 2025

Ingrid Kromann et al. Seven unresolved questions for vaccine science in 2025. Vaccine Insights March 2025; 4(1)

June Kim and Anna Särnefält. Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics. Vaccine Insights, October 2024; 3(7)

Franz Schnetzinger et al. Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release. Vaccines, September 2024; 12(9)

Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, et al. A Strategic Guide to Improve and De-risk Vaccine Development: CEPI’s CMC Framework. Journal of Pharmaceutical Science and Technology July 2024; 28(4)

Renske Hesselink et al. Improving vaccine equity by increasing vaccine thermostability. Science Translational Medicine July 2024; 16(757)

Ranna Eardley-Patel et al. The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.  The Lancet October 2023; 402(10412)

Ingrid Kromann, Anna Särnefält et al. Availability and use of Standards in vaccine development. Vaccines June 2023; 8(95)

Renske Hesselink et al. Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities. Expert Opinion on Drug Delivery January 2023; 20(3)

Matthew Downham Vaccine manufacturing: the future is global. Vaccine Insights November 2022; 1(6)

Benoit Hayman, Rajinder Kumar Suri and Matthew Downham. Sustainable vaccine manufacturing in low- and middle-Income countries. Vaccine November 2022; 40(50)